A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus
Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
|3||Not yet recruiting||
Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
† Study has passed its completion date and status has not been verified in more than two years.